Archrock Inc (AROC) is slightly undervalued and NOV Inc (NOV) is overvalued.
Against our estimates of intrinsic value, AROC trades at the wider discount: a margin of safety of +8%, against -86% for NOV.
Values as of the 19 Oct 2026 close.
Discounting its cash flows at 8.3% (average of 3 methods) values the shares at $31.99; the price of $29.39 is 8% below that value, and 79% of that value comes from beyond year five.
Leak Score 47/100 on 11 of 12 signals
Discounting its cash flows at 8.9% (average of 3 methods) values the shares at $10.08; the price of $18.75 is 86% above that value, and 76% of that value comes from beyond year five.
Leak Score 57/100 on 12 of 12 signals
| Metric | AROC | NOV |
|---|---|---|
| Verdict | Slightly undervalued | Overvalued |
| Price | $29.39 | $18.75 |
| Intrinsic value | $31.99 | $10.08 |
| Margin of safety | +8% | -86% |
| Leak Score | 47/100 (11/12) | 57/100 (12/12) |
| Market cap | $5.2B | $6.7B |
| Revenue growth, 5 years | 11.2% | 7.6% |
| Operating margin | 38.3% | 6.9% |
| Net margin | 21.6% | 1.1% |
| Return on equity | 21.9% | 1.5% |
| Debt to equity | 1.52 | 0.37 |
| P/E | 15.8x | 72.0x |
| Forward P/E | 14.3x | 14.8x |
| P/B | 3.3x | 1.1x |
| Dividend yield | 3.1% | 2.1% |